Schedule meeting @ AACR
Predicine is a global precision medicine company that has developed patented Gene RADAR technology, a RNA- and DNA-based liquid biopsy test for early cancer detection, disease monitoring and assessing minimal residual disease. With its integrated biomarker platform, vast data sets and advanced analytics, Predicine has partnered with 30+ biopharmas to support their clinical trials in US, EU, Australia and China. Predicine operates in US and China.
Stop by booth #2242 to learn more or submit your information below to request a meeting.
Schedule a meeting with us!
1. PWS: An integrated web service platform enabling precision medicine
2. Detection and validation of cancer immunotherapy biomarkers in blood
3. Non-invasive detection of fusion, splicing and mutation events from circulating cell-free RNA in cancers
4. Urine- and blood-based DNA+RNA liquid biopsy tests in prostate, bladder and kidney cancers
5. Analytical and clinical validation of blood-based NGS panel for detection of genomic alterations in DNA repair pathways
Next-Gen Liquid Biopsy Symposium
Apr 15, 6:30pm
Conference Onsite Hotel